Menu

  • Electrophysiology
  • Therapies & Procedures
  • Patient Care Portfolio
  • Education & Training

    • Leadless pacing just got smarter.

    Micra™ AV2 and Micra™ VR2 provide an unmatched leadless pacing experience for bradycardia patients. With improved battery longevity and smarter algorithms, most patients are projected to only need one device for life.2

    Increased battery longevity

    The world’s smallest leadless pacemakers now have projected median longevities of nearly 16–17 years, meaning more than 80% of patients are projected to only need one Micra™ device for life.2 These innovations required zero change to the device size.

    Enhanced delivery system

    The updated delivery system now has a rounded catheter tip with more surface area to decrease tip pressure during device implant.3 Micra™ AV2 and Micra™ VR2 devices are implanted with the same streamlined procedure that has been utilized by over 10,000 trained Micra™ physicians worldwide.4

    Clinical evidence

    Medtronic is following more than 30,000 patients in clinical research activities for Micra™ leadless pacemakers. Additionally, there have been more than 250 manuscripts published across the globe.4 Visit Medtronic Academy to learn more about our robust evidence.

    > 99%

    Implant success rate across multiple clinical studies.5–7

    ↓ 53%

    Reduction in both major complications and system revisions through three years.†,8

    < 5%

    Low rates of major complications and system revisions sustained through five years.†,8

    Micra™ leadless pacemaker videos

    Resources

    Patient Services

    1-888-660-4616
    Monday - Friday, 9 am to 5 pm
    Eastern Standard Time

    Educational resources on Medtronic Academy

    Access interactive courses, videos, and educational resources to extend your learning on Micra™ leadless pacemaker.

    Visit Medtronic Academy (open in new window)

    Related products